ArticleResearch in heart yield and translational medicine2025
The Prognostic Value of Residual Gensini Score on 1-Year Cardiac Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Article in Research in heart yield and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Highlights: The residual Gensini score is an independent predictor of 1-year cardiac mortality following PCI.A graded relationship exists between increasing rGensini and higher cardiac mortality risk.The rGensini score effectively identifies high-risk patients in the vulnerable early post-PCI period for intensified management. Background: Percutaneous coronary intervention (PCI) is a cornerstone in the management of obstructive coronary artery disease. The Gensini score quantitatively assesses the severity and complexity of coronary lesions. The residual Gensini score (rGensini), measured after PCI, may offer superior prognostic information compared with the baseline score. This study aimed to investigate the association between rGensini and cardiac mortality. Methods: In this study, all consecutive patients who registered for follow-up at the Afshar Hospital Health Promotion Center within 30 days after PCI were included. The primary outcome was cardiac mortality. Baseline characteristics, comorbidities (diabetes, hypertension, dyslipidemia, and prior cardiac history), smoking status, family history, coronary dominance pattern, and coronary calcification were recorded. Patients were stratified into four risk categories based on rGensini: zero-risk (0), low-risk (>0 to ≤11), moderate-risk (>11 to ≤37), and high-risk (>37). Survival analysis was performed using the Kaplan-Meier method, and independent predictors of cardiac mortality were identified using Cox proportional hazards regression. Results: The study included 141 patients (85 men and 56 women) with a mean age of 60.67 years. The mean Gensini score decreased from 31.22 at baseline to 18.20 after PCI. Over a median follow-up time of 9 months, 10 cardiac deaths occurred. Kaplan-Meier curves demonstrated a significant gradation in survival probability across the strata. Multivariable Cox regression analysis identified rGensini category, age, coronary calcification, diabetes, and hypertension as independent predictors of cardiac mortality. Conclusion: This hypothesis-generating study suggests that the rGensini score is a promising and independent predictor of cardiac mortality after PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.